These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6751023)

  • 41. Dissociation of insulin absorption and blood flow during massage of a subcutaneous injection site.
    Linde B
    Diabetes Care; 1986; 9(6):570-4. PubMed ID: 3542450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of three mathematical models to describe the disappearance curves of subcutaneously injected 125I-labelled insulin.
    De Meijer PH; Russel FG; Van Lier HJ; Van Ginneken CA
    Br J Clin Pharmacol; 1989 Apr; 27(4):461-7. PubMed ID: 2655689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of aprotinin on regional absorption of soluble human insulin.
    Owens DR; Vora JP; Birtwell J; Luzio S; Hayes TM
    Br J Clin Pharmacol; 1988 Apr; 25(4):453-6. PubMed ID: 2454647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
    Heinemann L; Linkeschova R; Rave K; Hompesch B; Sedlak M; Heise T
    Diabetes Care; 2000 May; 23(5):644-9. PubMed ID: 10834424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.
    Joseph SE; Korzon-Burakowska A; Woodworth JR; Evans M; Hopkins D; Janes JM; Amiel SA
    Diabetes Care; 1998 Dec; 21(12):2098-102. PubMed ID: 9839100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exercise augments the absorption of isophane (NPH) insulin.
    Thow JC; Johnson AB; Antsiferov M; Home PD
    Diabet Med; 1989; 6(4):342-5. PubMed ID: 2524341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.
    Lucidi P; Porcellati F; Marinelli Andreoli A; Carriero I; Candeloro P; Cioli P; Bolli GB; Fanelli CG
    Diabetes Care; 2015 Dec; 38(12):2204-10. PubMed ID: 26358287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on the absorption kinetics of subcutaneously administered insulin].
    Misawa K
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
    Ryysy L; Häkkinen AM; Goto T; Vehkavaara S; Westerbacka J; Halavaara J; Yki-Järvinen H
    Diabetes; 2000 May; 49(5):749-58. PubMed ID: 10905483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry.
    Vora JP; Burch A; Peters JR; Owens DR
    Diabetes Care; 1992 Nov; 15(11):1484-93. PubMed ID: 1334825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of insulin levels after injection by jet stream and disposable insulin syringe.
    Malone JI; Lowitt S; Grove NP; Shah SC
    Diabetes Care; 1986; 9(6):637-40. PubMed ID: 3542456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of insulin-induced hypoglycaemia on absorption of unmodified insulin after subcutaneous or intramuscular injection.
    Grønlund B; Frandsen H; Lauritzen M; Nielsen SL; Madsbad S
    Diabet Med; 1991 Jan; 8(1):13-7. PubMed ID: 1826237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin absorption and subcutaneous blood flow in normal subjects during insulin-induced hypoglycemia.
    Fernqvist-Forbes E; Linde B; Gunnarsson R
    J Clin Endocrinol Metab; 1988 Sep; 67(3):619-23. PubMed ID: 3045145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs.
    Markussen J; Havelund S; Kurtzhals P; Andersen AS; Halstrøm J; Hasselager E; Larsen UD; Ribel U; Schäffer L; Vad K; Jonassen I
    Diabetologia; 1996 Mar; 39(3):281-8. PubMed ID: 8721773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique.
    Bottermann P; Gyaram H; Wahl K; Ermler R; Lebender A
    Diabetes Care; 1982; 5 Suppl 2():43-52. PubMed ID: 6765540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of continuous subcutaneous insulin infusion.
    Lauritzen T; Pramming S; Deckert T; Binder C
    Diabetologia; 1983 May; 24(5):326-9. PubMed ID: 6347780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel hepatoselective insulin analog: studies with a covalently linked thyroxyl-insulin complex in humans.
    Shojaee-Moradie F; Powrie JK; Sundermann E; Spring MW; Schüttler A; Sönksen PH; Brandenburg D; Jones RH
    Diabetes Care; 2000 Aug; 23(8):1124-9. PubMed ID: 10937509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaceutical approach to subcutaneous dosage forms of insulin.
    Hori R; Komada F; Okumura K
    J Pharm Sci; 1983 Apr; 72(4):435-9. PubMed ID: 6191020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.